Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireJan 17 16:30 ET

Express News | Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

ReutersJan 17 16:30 ET

Why Ultragenyx Pharmaceutical (RARE) Is the Biotech Stock With the Biggest Upside Potential

Yahoo FinanceJan 17 11:14 ET

Evercore Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $70

Moomoo NewsJan 16 08:33 ET · Ratings

A Quick Look at Today's Ratings for Ultragenyx Pharmaceutical(RARE.US), With a Forecast Between $48 to $140

Moomoo NewsJan 14 08:00 ET · Ratings

Ultragenyx Pharma Is Maintained at Overweight by Piper Sandler

Dow JonesJan 13 10:37 ET · Ratings